City
Epaper

Guyana recognises Covaxin

By IANS | Updated: November 2, 2021 14:10 IST

New Delhi, Nov 2 Guyana on Tuesday recognised Bharat Biotech's Covaxin, India's first indigenous vaccine against Covid-19.Hailing ...

Open in App

New Delhi, Nov 2 Guyana on Tuesday recognised Bharat Biotech's Covaxin, India's first indigenous vaccine against Covid-19.

Hailing the decision, the Indian High Commission in Guyana said that it is an important step forward in the post Covid partnership between both the countries.

On Monday, Australia also recognised Covaxin for allowing entry of travellers who had received the vaccine and five other countries also recognised the Indian vaccine certificate.

In a tweet, the High Commission of India in Guyana said, "Guyana has recognised India's indigenous vaccine Covaxin -important step forward in the post-COVID partnership between India and Guyana.

"Now, all passengers aged 18 years and above travelling to Guyana must be vaccinated against Covid-19 before arrival. Passengers are required to present their vaccination card bearing their name of vaccine, date vaccine was inoculated and batch from an accredited facility."

On Monday, the Ministry of External Affairs (MEA) said that five more countries Estonia, Kyrgyzstan, State of Palestine, Mauritius and Mongolia have recognised India's vaccination certificate.

In a tweet in the evening, MEA spokesperson Arindam Bagchi said, "Mutual recognition of COVID-19 vaccination certificates continues! Five more recognitions for India's vaccination certificate, including from Estonia, Kyrgyzstan, State of Palestine, Mauritius and Mongolia."

"Australia had recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine. The Therapeutic Goods Administration (TGA), the Australian drug regulator, announced that it has recognised two more Covid-19 vaccines not registered in Australia but used widely internationally, which includes Bharat Biotech's Covaxin and BBIBP-CorV (manufactured by Sinopharm, China).

The TGA stated that with the recognition of Covaxin, and BBIBP-CorV, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca, India), many citizens of India and China as well as other countries in the region where these vaccines have been widely deployed will now be considered fully vaccinated on entry to Australia.

The TGA stated that it will facilitate the return of international students, and travel of skilled and unskilled workers to Australia.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat Biotech InternationalArindam bagchiNew DelhiIndian High CommissionPalestineThe new delhi municipal councilDelhi south-westBharat biotech limitedBharat biotech international ltdBharat biotech companyNew-delhi
Open in App

Related Stories

National‘Harassing Crores for a Few’: Ex-CEC S.Y. Quraishi Criticises SIR Process at Lokmat National Conclave 2025

NationalLokmat National Conclave 2025: Manoj Jha Flags ‘Freebies Culture’, Says Elections Are No Longer Fair

CricketVirat Kohli Spotted at Delhi Airport Ahead of India's Tour of Australia, Video Goes Viral

InternationalGaza Ceasefire: Palestinians Set to Return as Israel Continues Bombing, Says Agreement Starts at Noon

InternationalUS Government Shutdown: US Embassy in India’s X Account to Pause Regular Updates Until Full Operations Resume

Health Realted Stories

HealthDelhi: Nangloi gets upgraded Ayushman Aarogya Mandir to boost local healthcare

Health'Challenges won't be resolved by speaking ill of each other': Vijayvargiya slams Cong over Indore clean city tag

HealthHealth experts, advocates call for systemic reforms to protect transfusion-dependent patients

HealthNo Time for Gym? Try ‘Exercise Snacks’ to Stay Fit in a Busy Lifestyle

HealthSPF 30 vs SPF 50 Sunscreen: Is Higher SPF Better?